Literature DB >> 1566997

Oxyhaemoglobin saturation following elective abdominal surgery in patients receiving continuous intravenous infusion or intramuscular morphine analgesia.

M T Kluger1, H Owen, D Watson, A H Ilsley, A M Baldwin, R R Fronsko, J L Plummer, W G Brose.   

Abstract

Oxygen saturation was continuously measured using computerised pulse oximetry for 8 h overnight pre-operatively and for the first 24 h postoperatively in 40 patients receiving intermittent intramuscular morphine or continuous infusion of morphine following elective upper abdominal surgery. The proportion of time with an oxygen saturation less than 94% was used as an index of desaturation. Patients receiving continuous infusion analgesia received a larger morphine dose and achieved better analgesia than the intramuscular group. Postoperatively, the duration of desaturation increased 10-fold over pre-operative values, 'intramuscular' patients spending 39.0% (SD, 37.0%) and 'continuous infusion' patients 40.0% (SD, 37.5%) of the time below 94% saturation. Although newer therapies (e.g. epidural analgesia and patient-controlled analgesia) are currently receiving greater attention, the sequelae of these more traditional analgesic techniques warrant further study.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1566997     DOI: 10.1111/j.1365-2044.1992.tb02131.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  3 in total

1.  Postoperative pain control in children.

Authors:  N S Morton; L R McNicol
Journal:  BMJ       Date:  1992-05-02

2.  Emergency analgesia in the paediatric population. Part IV Paediatric sedation in the accident and emergency department: pros and cons.

Authors:  E Doyle
Journal:  Emerg Med J       Date:  2002-07       Impact factor: 2.740

3.  Principles & guidelines for respiratory monitoring on the general care floor. The Consortium on Respiratory Monitoring on the General Care Floor.

Authors: 
Journal:  J Clin Monit       Date:  1996-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.